A detailed history of Tema Etfs LLC transactions in Amgen Inc stock. As of the latest transaction made, Tema Etfs LLC holds 20,132 shares of AMGN stock, worth $6.88 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
20,132
Previous 17,964 12.07%
Holding current value
$6.88 Million
Previous $5.07 Billion 29.98%
% of portfolio
0.51%
Previous 0.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

BUY
$290.13 - $341.71 $629,001 - $740,827
2,168 Added 12.07%
20,132 $6.59 Billion
Q3 2025

Oct 24, 2025

BUY
$271.18 - $309.22 $1.35 Million - $1.54 Million
4,987 Added 38.43%
17,964 $5.07 Billion
Q2 2025

Aug 13, 2025

BUY
$262.28 - $309.85 $850,574 - $1 Million
3,243 Added 33.32%
12,977 $3.62 Billion
Q1 2025

May 14, 2025

SELL
$258.59 - $327.36 $373,662 - $473,035
-1,445 Reduced 12.93%
9,734 $3.03 Billion
Q4 2024

Feb 14, 2025

BUY
$258.78 - $328.31 $2.89 Million - $3.67 Million
11,179 New
11,179 $2.91 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.